Diaz Adriana Lizzeth purchased $94K of BLX

Diaz Adriana Lizzeth (Chief Audit Officer) purchased 1,792 shares of BLADEX, INC. (BLX) at $52.39 on 2026-10-30.

Original reporting
SEC EDGAR · Diaz Adriana Lizzeth
Published Nov 2, 2026, 3:24 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 3:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BLX
Neutral
high confidence
Mentioned
$BLX
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BLXNeutralLow
01

Why it matters

The filing adds a new data point on insider activity for BLADEX, but the modest size limits market reaction.

02

Market read

A routine insider purchase with limited impact; may be noted by short‑term traders but unlikely to move the stock materially.

03

What to watch

If the insider has material non‑public information, the trade could be more significant.

Relevance 4/10Novelty 4/10Timing: today

Background

SEC Form 4 filings disclose insider transactions; investors monitor them for signals of confidence or distress.

Company-level read

Ticker impact

$BLXNeutralHigh confidence
Context

Chief Audit Officer purchased 1,792 shares for $93,883, increasing holdings to 15,090 shares.

Expected impact

slight upward pressure as market prices in insider confidence

Evidence & confidence

The transaction size is modest relative to market cap and represents a routine 10b5‑1‑free purchase.

Market effects

None

None

None

Counterpoint

The purchase is too small to affect price; traders may ignore.

Key entities

  • Diaz Adriana Lizzeth

    Chief Audit Officer of BLADEX, Inc.

  • BLADEX, Inc.

    US‑listed provider of blockchain‑based solutions.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BLXMed

Bladex Earnings Call Shows Record Growth Amid Margin Pressure

Banco Latinoamericano de Comercio (BLX) reported Q3 record portfolio growth of $15B, up 15% sequentially and 38% YoY. Net income rose 15% YoY to $63.2M but fell 5% sequentially due to higher costs and provisions. Management expects margin compression and lending spread pressure, citing intense competition for Latin American assets. The company maintained its dividend at $0.6875 per share.

$BLXHighAI 8/10

BLADEX, INC. (BLX): Financial results for Q3 2026

BLADEX, INC. (BLX) furnished an SEC Form 6-K — earnings release. o SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BLADEX, INC. (Registrant) Date: October 28, 2026 By: /s/ Annette van Hoorde de So

$BLXMedAI 8/10

Bladex Inc (BLX) Q3 2026 Earnings Call Highlights: Record Portfolio and Net Interest

Bladex Inc (BLX) reported Q3 2026 earnings with record commercial portfolio at $15B, up 15% QoQ, and net interest income at $79.8M, up 9% QoQ. Credit quality remained strong, but net interest margin faces pressure. Guidance includes full-year NIM compression to ~2.25%. Loan growth is concentrated in short-term exposures, potentially slowing 2027 growth. The Panama sovereign loan is dilutive to NIM but contributes to NII.

Med

Bladex Grants Panama a Record US$1 Billion Loan

Bladex, a Panama-based trade bank, has granted Panama's government a record US$1 billion loan. The senior loan, announced on 15 September 2026, is for general budgetary purposes. Panama has been diversifying its financing sources amid credit rating pressures.

$BLXHigh

BLADEX, INC. (BLX): Financial results for Q2 2026

BLADEX, INC. (BLX) furnished an SEC Form 6-K — earnings release. o SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BLADEX, INC. (Registrant) Date: July 28, 2026 By: /s/ Annette van Hoorde de Solís